Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
J Am Chem Soc ; 141(36): 14026-14031, 2019 09 11.
Artículo en Inglés | MEDLINE | ID: mdl-31436970

RESUMEN

The development of a synthetic code that enables a sequence programmable feature like DNA represents a key aspect toward intelligent molecular systems. We developed herein the well-known dynamic covalent interaction between boronic acids (BAs) and catechols (CAs) into synthetic nucleobase analogs. Along a defined peptide backbone, BA or CA residues are arranged to enable sequence recognition to their complementary strand. Dynamic strand displacement and errors were elucidated thermodynamically to show that sequences are able to specifically select their partners. Unlike DNA, the pH dependency of BA/CA binding enables the dehybridization of complementary strands at pH 5.0. In addition, we demonstrate the sequence recognition at the macromolecular level by conjugating the cytochrome c protein to a complementary polyethylene glycol chain in a site-directed fashion.

3.
Macromol Biosci ; 18(10): e1800196, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30066983

RESUMEN

Protein-based polymeric polyelectrolytes are emerging as alternative synthetic nanoparticles owing to their biodegradability and biocompatibility. However, potential in vivo toxicity remains a significant challenge. Herein an array of protein polyelectrolytes generated from cationic human serum albumin (cHSA) and polyethylene glycol (PEG) are synthesized via synthetic customization as antimicrobials for the treatment of systemic infections. By varying PEG molecular weight and chain length, in vitro hemolytic activity can be fine-tuned without significantly affecting antimicrobial potency. The optimal hybrid material, PEG (2000)18 -cHSA, with potent antimicrobial character, low hemolytic activity, and in vitro biofilm disruptive properties is identified. Surface plasmon resonance (SPR) evaluation demonstrates significantly higher binding activity of the protein nanoparticles to bacteria cell wall components and microfluidic live-cell imaging indicates that the nanoparticles act through a membranolytic mechanism. Given their low susceptibility to drug resistance and potent activity against resistant bacteria strains, these findings establish the PEGylated albumin nanoparticles as a potent weaponry against drug resistance and biofilm-related infection.


Asunto(s)
Antibacterianos , Bacterias/crecimiento & desarrollo , Fenómenos Fisiológicos Bacterianos/efectos de los fármacos , Biopelículas/efectos de los fármacos , Candida albicans/fisiología , Eritrocitos/metabolismo , Hemólisis/efectos de los fármacos , Nanopartículas/química , Albúmina Sérica Humana , Antibacterianos/síntesis química , Antibacterianos/química , Antibacterianos/farmacología , Biopelículas/crecimiento & desarrollo , Eritrocitos/citología , Humanos , Polietilenglicoles/química , Albúmina Sérica Humana/química , Albúmina Sérica Humana/farmacología
4.
Adv Sci (Weinh) ; 5(8): 1701036, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-30128225

RESUMEN

A facile chemical approach integrating supramolecular chemistry, site-selective protein chemistry, and molecular biology is described to engineer synthetic multidomain protein therapeutics that sensitize cancer cells selectively to significantly enhance antitumor efficacy of existing chemotherapeutics. The desired bioactive entities are assembled via supramolecular interactions at the nanoscale into structurally ordered multiprotein complexes comprising a) multiple copies of the chemically modified cyclic peptide hormone somatostatin for selective targeting and internalization into human A549 lung cancer cells expressing SST-2 receptors and b) a new cysteine mutant of the C3bot1 (C3) enzyme from Clostridium botulinum, a Rho protein inhibitor that affects and influences intracellular Rho-mediated processes like endothelial cell migration and blood vessel formation. The multidomain protein complex, SST3-Avi-C3, retargets C3 enzyme into non-small cell lung A549 cancer cells and exhibits exceptional tumor inhibition at a concentration ≈100-fold lower than the clinically approved antibody bevacizumab (Avastin) in vivo. Notably, SST3-Avi-C3 increases tumor sensitivity to a conventional chemotherapeutic (doxorubicin) in vivo. These findings show that the integrated approach holds vast promise to expand the current repertoire of multidomain protein complexes and can pave the way to important new developments in the area of targeted and combination cancer therapy.

5.
Bioconjug Chem ; 29(1): 29-34, 2018 01 17.
Artículo en Inglés | MEDLINE | ID: mdl-29231709

RESUMEN

The attachment of two different functionalities in a site-selective fashion represents a great challenge in protein chemistry. We report site specific dual functionalizations of peptides and proteins capitalizing on reactivity differences of cysteines in their free (thiol) and protected, oxidized (disulfide) forms. The dual functionalization of interleukin 2 and EYFP proceeded with no loss of bioactivity in a stepwise fashion applying maleimide and disulfide rebridging allyl-sulfone groups. In order to ensure broader applicability of the functionalization strategy, a novel, short peptide sequence that introduces a disulfide bridge was designed and site-selective dual labeling in the presence of biogenic groups was successfully demonstrated.


Asunto(s)
Compuestos Alílicos/química , Cisteína/química , Maleimidas/química , Péptidos/química , Proteínas/química , Compuestos de Sulfhidrilo/química , Sulfonas/química , Compuestos Alílicos/síntesis química , Animales , Proteínas Bacterianas/síntesis química , Proteínas Bacterianas/química , Línea Celular , Cisteína/síntesis química , Humanos , Interleucina-2/síntesis química , Interleucina-2/química , Proteínas Luminiscentes/síntesis química , Proteínas Luminiscentes/química , Maleimidas/síntesis química , Ratones , Modelos Moleculares , Péptidos/síntesis química , Proteínas/síntesis química , Proteínas Recombinantes/síntesis química , Proteínas Recombinantes/química , Coloración y Etiquetado/métodos , Compuestos de Sulfhidrilo/síntesis química , Sulfonas/síntesis química
6.
ACS Macro Lett ; 6(3): 241-246, 2017 Mar 21.
Artículo en Inglés | MEDLINE | ID: mdl-35650920

RESUMEN

Peptide-polymer conjugates have been regarded as primary stronghold in biohybrid nanomedicine, which has seen extensive development due to its intrinsic property to provide complementary functions of both the peptide material and the synthetic polymer platform. Here we present an advanced macromolecular therapeutic that targets two exclusive classes of important diseases (namely, the HIV and cancer) that are implicated by extremely different causative agents. Using a facile thiol-reactive monomer, the eventual polymer facilitates multivalent conjugation of an endogenous peptide WSC02 that targets the CXCR4 chemokine receptor. The biohybrid material demonstrated both potent antiviral effects against HIV-1 as well as inhibiting cancer stem cell migration thus establishing the foundation for multimodal nanotherapeutics that simultaneously target more than one class of disease implications.

7.
Chem Sci ; 7(5): 3234-3239, 2016 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-29997815

RESUMEN

Water-soluble allyl sulfones provide convenient site-specific disulfide rebridging of native proteins and cyclic peptides. The site-selective functionalization of (a) the peptide hormone somatostatin, (b) the interchain disulfide of bovine insulin and (c) functionalization of the proteins GFP and lysozyme with allyl sulfones proceeds in aqueous solution. Allyl sulfones offer three functionalizable sites that react with thiol containing molecules in a step-wise fashion. Dual labeling of proteins and cyclic peptides is achieved i.e. the attachment of a chromophore and an affinity tag in a single reaction step, which is of great significance for the construction of precise multifunctional peptide and protein conjugates.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...